Unfavorable prognosis of patients with non-small cell lung carcinoma associated with HLA-A2

Lung Cancer

Volumn 32, Issue 1, 2001, Pages 39-46

  So, Tomoko ^a   Takenoyama, Mitsuhiro ^a   Sugaya, Masakazu ^a   Yasuda, Manabu ^a   Eifuku, Ryozo ^a   Yoshimatsu, Takashi ^a   Osaki, Toshihiro ^a   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Disease free survival; HLA A2; Immune surveillance; Non small cell lung carcinoma

Indexed keywords

HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CANCER SURVIVAL; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; DISEASE ASSOCIATION; FEMALE; HAPLOTYPE; HUMAN; IMMUNOSURVEILLANCE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SEROTYPING; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURVIVAL RATE; SURVIVAL TIME; CANCER STAGING; DISEASE FREE SURVIVAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LUNG TUMOR; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-A2 ANTIGEN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS;

EID: 0035320922     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0169-5002(00)00204-x     Document Type: Article

References (27)

1. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia
2. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines
3. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer
4. Tumor escape from immune response by variation in HLA expression and other mechanisms
5. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo
6. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours
7. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma
8. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer
9. HLA and cancer: from research to clinical impact
10. Immunological ignorance of silent antigens as an explanation of tumor evasion
11. Kinetic analysis of recurrence and survival after potentially curative resection of non-small cell lung cancer
12. Ankylosing spondylitis and HL-A 27
13. Association of Behcet's disease and pelvispondylitis in a subject without HLA W 27 antigen
14. Subacute (de Quervain's) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins
15. HLA and prognostic factors in primary breast cancer
16. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3
17. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger
18. HLA antigen in Chinese patients with hepatocellular carcinomas
19. Prolonged survival in bronchogenic carcinoma associated with HL-A antigens W-19 and HL-A5: a preliminary report
20. Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. A two-year prospective study
21. HLA antigens and primary bronchial carcinoma
22. HLA and survival in lung cancer
23. HLA antigens and bronchogenic carcinoma
24. The 1997 International Staging System for non-small cell lung cancer: have all the issues been addressed?
25. Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals
26. HLA antigens in bronchogenic carcinoma
27. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups